Moneycontrol

Markets

  • Sensex
    36496.37
    145.14 (0.40%)
  • Nifty
    11010.20
    53.10 (0.48%)

Reliance Pharma Fund (G)

Plan: Regular | Option: Growth | Type : Open-Ended | AMFI Code: 102431
Fact Sheet Buy
139.177 -1.52 ( -1.08 %)
NAV as on 19 Jul, 2018
Crisil MF Rank
Riskometer
HIGH
Success
Alert
Please select a Day.
Info

Not Ranked

The scheme is Not Ranked in Sector - Pharma & Healthcare category by Crisil (for quarter ended Mar 2018 ) from last quarter. If you are already invested in this scheme, you may continue to stay invested. But, do keep a check on its performance.

Chart

  • Benchmark Index

  • View Historic Graph

Returns (NAV as on Jul 19, 2018)
Period Returns(%) Rank#
1 Month -3.9 6
3 Months -1.9 2
6 Months -3.8 2
1 Year 2.2 2
2 Years 0.5 2
3 Years -0.7 2
5 Years 13.7 2

# Moneycontrol Rank within 12 Sector - Pharma & Healthcare Schemes

*Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Absolute Returns (in %)
Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2018 -7.1 7.0 - - -
2017 0.7 -5.9 -0.1 12.1 7.4
2016 -12.3 2.2 6.4 -8.4 -10.5
2015 9.5 -4.4 14.2 -3.4 19.3
2014 3.5 10.8 25.0 3.4 48.5
2013 -6.3 5.4 3.2 14.6 20.5

View where it stands within its peers

Return Calculator SIP Calculator

Performance

Fund returns v/s Category average (Large Cap)

* Returns over 1 year are Annualised
  1mth(%) 3mth(%) 6mth(%) 1yr(%) 2yr(%) 3yr(%) 5yr(%)
Fund Returns -3.9 -1.9 -3.8 2.2 0.5 -0.7 13.7
Category average -2.6 -3.1 -6.3 -4.6 -4 -2.9 5.4
Difference of Fund returns and Category returns -1.3 1.2 2.5 6.8 4.5 2.2 8.3
Best of Category -1.5 -1 -2.4 4.8 0.9 0.3 14.9
Worst of Category -5.6 -8.8 -16.2 -14.8 -12.2 -9.8 8.9
Benchmark returns # -4.3 -1.2 -8.7 -8.4 -8.9 -8.6 0
Difference of Fund returns and Benchmark returns 0.4 -0.7 4.9 10.6 9.4 7.9 13.7
# Benchmark Index: S&P BSE HEALTHCARE

Investment Information

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Registrars
Load Details
  • Entry Load:

    N.A

  • Exit Load:

    1.00%

  • Load Comments:

    Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment.

Contact Details
peer comparison
Fund Crisil Rank Assets(Rs Cr.) Current NAV 3mth(%) 6mth(%) 1yr(%) 3yr(%) 5yr(%)
Reliance Pharma Fund (G) 1,724.94 139.2 -1.9 -3.8 2.2 -0.7 13.7
SBI Healthcare Opportunities Fund (G) 755.55 109.8 -9.4 -16.8 -16.0 -10.0 9.9
UTI Healthcare Fund (G) 357.08 81.5 -3.9 -10.4 -7.2 -6.8 8.7
Reliance Pharma Fund - Direct Plan (G) 266.67 145.7 -1.8 -3.4 3.1 0.2 14.6
SBI Healthcare Opportunities Fund - Direct Plan (G) 204.85 116.7 -9.1 -16.3 -14.9 -8.9 11.2
*Returns over 1 year are Annualised

Portfolio

Top 10 Holdings As on Jun 30, 2018
Company Sector Value %Assets
Sun Pharma Pharmaceuticals 169.12 11.05
Cipla Pharmaceuticals 148.54 9.78
Dr Reddys Labs Pharmaceuticals 120.18 9.21
Divis Labs Pharmaceuticals 159.26 8.59
Aurobindo Pharm Pharmaceuticals 131.25 8.35
Lupin Pharmaceuticals 89.23 7.59
Abbott India Pharmaceuticals 191.08 7.37
Biocon Pharmaceuticals 127.44 6.95
Sanofi India Pharmaceuticals 144.39 6.82
Thyrocare Techn Services 117.93 5.16
Asset Allocation (%) As on Jun 30, 2018
Equity 97.90
Others 0.34
Debt 0.00
Mutual Funds 0.00
Money Market 1.69
Cash / Call 0.07
Sector Allocation (%) As on Jun 30, 2018
Sector %
Pharmaceuticals 86.42
Services 10.41
Manufacturing 1.01
Miscellaneous 0.06
Concentration As on Jun 30, 2018
Holdings %
Top 5 46.98
Top 10 97.9
Sectors %
Top 3 97.84
News & Videos
Forum | Add a comment...

What`s Your Opinion

Will you invest in a IT-dedicated Mutual Fund scheme?

  • Yes
  • No

Submit

See More

Last Visited
Sections
Follow us on
Available On